180 related articles for article (PubMed ID: 34661077)
1. Discovery and Characterization of Novel Antagonists of the Proinflammatory Orphan Receptor GPR84.
Jenkins L; Marsango S; Mancini S; Mahmud ZA; Morrison A; McElroy SP; Bennett KA; Barnes M; Tobin AB; Tikhonova IG; Milligan G
ACS Pharmacol Transl Sci; 2021 Oct; 4(5):1598-1613. PubMed ID: 34661077
[TBL] [Abstract][Full Text] [Related]
2. Investigating the Structure-Activity Relationship of 1,2,4-Triazine G-Protein-Coupled Receptor 84 (GPR84) Antagonists.
Mahindra A; Jenkins L; Marsango S; Huggett M; Huggett M; Robinson L; Gillespie J; Rajamanickam M; Morrison A; McElroy S; Tikhonova IG; Milligan G; Jamieson AG
J Med Chem; 2022 Aug; 65(16):11270-11290. PubMed ID: 35948061
[TBL] [Abstract][Full Text] [Related]
3. On-target and off-target effects of novel orthosteric and allosteric activators of GPR84.
Mancini SJ; Mahmud ZA; Jenkins L; Bolognini D; Newman R; Barnes M; Edye ME; McMahon SB; Tobin AB; Milligan G
Sci Rep; 2019 Feb; 9(1):1861. PubMed ID: 30755705
[TBL] [Abstract][Full Text] [Related]
4. Modulation of the G-Protein-Coupled Receptor 84 (GPR84) by Agonists and Antagonists.
Chen LH; Zhang Q; Xie X; Nan FJ
J Med Chem; 2020 Dec; 63(24):15399-15409. PubMed ID: 33267584
[TBL] [Abstract][Full Text] [Related]
5. Three classes of ligands each bind to distinct sites on the orphan G protein-coupled receptor GPR84.
Mahmud ZA; Jenkins L; Ulven T; Labéguère F; Gosmini R; De Vos S; Hudson BD; Tikhonova IG; Milligan G
Sci Rep; 2017 Dec; 7(1):17953. PubMed ID: 29263400
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic validation of an orphan G protein-coupled receptor: The case of GPR84.
Marsango S; Barki N; Jenkins L; Tobin AB; Milligan G
Br J Pharmacol; 2022 Jul; 179(14):3529-3541. PubMed ID: 32869860
[TBL] [Abstract][Full Text] [Related]
7. The Medium-Chain Fatty Acid Receptor GPR84 Mediates Myeloid Cell Infiltration Promoting Steatohepatitis and Fibrosis.
Puengel T; De Vos S; Hundertmark J; Kohlhepp M; Guldiken N; Pujuguet P; Auberval M; Marsais F; Shoji KF; Saniere L; Trautwein C; Luedde T; Strnad P; Brys R; Clément-Lacroix P; Tacke F
J Clin Med; 2020 Apr; 9(4):. PubMed ID: 32316235
[TBL] [Abstract][Full Text] [Related]
8. An Agonist Radioligand for the Proinflammatory Lipid-Activated G Protein-Coupled Receptor GPR84 Providing Structural Insights.
Köse M; Pillaiyar T; Namasivayam V; De Filippo E; Sylvester K; Ulven T; von Kügelgen I; Müller CE
J Med Chem; 2020 Mar; 63(5):2391-2410. PubMed ID: 31721581
[TBL] [Abstract][Full Text] [Related]
9. Molecular characterization of GPR84 in domestic cats.
Yamamoto I; Michishita M; Fujita K; Sakai T; Sasaki N; Kawasumi K
Gen Comp Endocrinol; 2024 Jul; 353():114520. PubMed ID: 38641150
[TBL] [Abstract][Full Text] [Related]
10. 20 Years an Orphan: Is GPR84 a Plausible Medium-Chain Fatty Acid-Sensing Receptor?
Luscombe VB; Lucy D; Bataille CJR; Russell AJ; Greaves DR
DNA Cell Biol; 2020 Nov; 39(11):1926-1937. PubMed ID: 33001759
[TBL] [Abstract][Full Text] [Related]
11. Pro-phagocytic function and structural basis of GPR84 signaling.
Zhang X; Wang Y; Supekar S; Cao X; Zhou J; Dang J; Chen S; Jenkins L; Marsango S; Li X; Liu G; Milligan G; Feng M; Fan H; Gong W; Zhang C
Res Sq; 2023 Feb; ():. PubMed ID: 36824923
[TBL] [Abstract][Full Text] [Related]
12. Discovery and Characterization of a Novel Small-Molecule Agonist for Medium-Chain Free Fatty Acid Receptor G Protein-Coupled Receptor 84.
Zhang Q; Yang H; Li J; Xie X
J Pharmacol Exp Ther; 2016 May; 357(2):337-44. PubMed ID: 26962172
[TBL] [Abstract][Full Text] [Related]
13. Medium-chain fatty acids as ligands for orphan G protein-coupled receptor GPR84.
Wang J; Wu X; Simonavicius N; Tian H; Ling L
J Biol Chem; 2006 Nov; 281(45):34457-64. PubMed ID: 16966319
[TBL] [Abstract][Full Text] [Related]
14. Biased agonists of GPR84 and insights into biological control.
Luscombe VB; Wang P; Russell AJ; Greaves DR
Br J Pharmacol; 2024 May; 181(10):1509-1523. PubMed ID: 38148720
[TBL] [Abstract][Full Text] [Related]
15. Phosphodiesters as GPR84 Antagonists for the Treatment of Ulcerative Colitis.
Chen LH; Zhang Q; Xiao YF; Fang YC; Xie X; Nan FJ
J Med Chem; 2022 Mar; 65(5):3991-4006. PubMed ID: 35195005
[TBL] [Abstract][Full Text] [Related]
16. Pro-phagocytic function and structural basis of GPR84 signaling.
Zhang X; Wang Y; Supekar S; Cao X; Zhou J; Dang J; Chen S; Jenkins L; Marsango S; Li X; Liu G; Milligan G; Feng M; Fan H; Gong W; Zhang C
Nat Commun; 2023 Sep; 14(1):5706. PubMed ID: 37709767
[TBL] [Abstract][Full Text] [Related]
17. Embelin and its derivatives unravel the signaling, proinflammatory and antiatherogenic properties of GPR84 receptor.
Gaidarov I; Anthony T; Gatlin J; Chen X; Mills D; Solomon M; Han S; Semple G; Unett DJ
Pharmacol Res; 2018 May; 131():185-198. PubMed ID: 29471103
[TBL] [Abstract][Full Text] [Related]
18. Structural insights into ligand recognition and activation of the medium-chain fatty acid-sensing receptor GPR84.
Liu H; Zhang Q; He X; Jiang M; Wang S; Yan X; Cheng X; Liu Y; Nan FJ; Xu HE; Xie X; Yin W
Nat Commun; 2023 Jun; 14(1):3271. PubMed ID: 37277332
[TBL] [Abstract][Full Text] [Related]
19. Diindolylmethane Derivatives: Potent Agonists of the Immunostimulatory Orphan G Protein-Coupled Receptor GPR84.
Pillaiyar T; Köse M; Sylvester K; Weighardt H; Thimm D; Borges G; Förster I; von Kügelgen I; Müller CE
J Med Chem; 2017 May; 60(9):3636-3655. PubMed ID: 28406627
[TBL] [Abstract][Full Text] [Related]
20. Similarities and differences between the responses induced in human phagocytes through activation of the medium chain fatty acid receptor GPR84 and the short chain fatty acid receptor FFA2R.
Sundqvist M; Christenson K; Holdfeldt A; Gabl M; Mårtensson J; Björkman L; Dieckmann R; Dahlgren C; Forsman H
Biochim Biophys Acta Mol Cell Res; 2018 May; 1865(5):695-708. PubMed ID: 29477577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
